Blog Main Takeaways:
  • There is a considerable amount of misinformation about the Endocannabinoid System
  • Currently there no standard guidelines for cannabinoids  because they have removed it from under the nutritional supplement umbrella due to a new pharmaceutically made isolate CBD product approved for seizures.
  • The World Health Organization (WHO) listing 17 diseases where CBD “may have therapeutic benefits” and the clearing of CBD from the World Anti-doping Agency list of prohibited substances.
  • With over 30,000 studies and 30 million dollars in research already done and more happening all over the world Sucavu will be using that information to create better targeted products
With the passing of the Farm bill and Forbes projections for growth, 2019 was touted as the year of CBD. In 2020 we are making way for a huge industry shift to the “Decade of Cannabinoids”.  Sucavu has always been a cannabinoid company and have set ourselves apart as an industry leader.  Based on world wide research studies, we saw the future 6 years ago and started moving in that direction. We have a mission to educate the 2 paradoxical cannabinoid camps: one where it is being touted as a “miracle plant” because of its effectiveness , the other calling it “snake oil”, from people who can’t understand why they felt nothing .

Most of these opposing positions stem from misinformation about our own endocannabinoid system as well as confusing and conflicting information provided by governing bodies world wide, all tip toeing around the research.

In the US, we have the  FDA who would normally regulate natural plant products. However, currently there no standard guidelines for cannabinoids  because they have removed it from under the nutritional supplement umbrella due to a new pharmaceutically made isolate CBD product approved for seizures.  This unfortunately diminished regulation of quality and labeling focusing it’s efforts based on general disdain of any health claims.  This position by the FDA opposes the general populace who want the government to give cannabinoids back to “the people”. Unfortunately “ the people” do not understanding some of the inherent dangers of toxins pulled out because of the soil remediation benefits of the plant.  In fact there were over 1500 reported poisonings to the National poison control center leading to a relative nightmare of no regulation and unscrupulous companies with dangerous products on the market just looking to make a quick buck. In 2019 over 1500 US poison control center cases were filed  and already 144 cases in January 2020 .

 Next, to add to the confusion, internationally we have the World Health Organization (WHO) listing 17 diseases where CBD “may have therapeutic benefits” and the clearing of CBD from the World Anti-doping Agency list of prohibited substances.   This leads to greater misunderstanding from those who have not seen any benefits but don’t want to be left out. People are wanting education from reliable sources about cannabinoids and they want their own results to prove it. They want the science. They want accountability and transparency in the growing, extraction, product analysis and manufacturing.  Sucavu will continue to give them that transparency and support with it’s mission of providing the most real spectrum cannabinoids in any product, grown and produced from “Soil to Soul”.  With over 30,000 studies and 30 million dollars in research already done and more happening all over the world Sucavu will be using that information to create better targeted products and a build a massive community of people who care and are willing to connect about their experience.  Sucavu will be the leaders in additional cannabinoids and we will continue to manufacture product lines based on cutting edge research that is being conducted all over the world.